July 9 (UPI) -- The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as Wegovy, will soon expire.
Hims & Hers also said in a press release Wednesday that it acquired the European digital health platform ZAVA, which carries Wegovy.
Novo Nordisk declared last month it had stopped allowing Hims & Hers to sell Wegovy in its pharmacy due to allegations of "disseminating deceptive marketing" and mass sales of compounded drugs under the pretense of "personalization."
However, with ZAVA, Hims & Hers can better reach across markets, and reports it plans to bring semaglutides in Canada.
Related
